Wed, July 26, 2023
Tue, July 25, 2023
Mon, July 24, 2023

William Plovanic Maintained (YMAB) at Strong Buy with Increased Target to $22 on, Jul 25th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-22-on-jul-25th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

William Plovanic of Canaccord Genuity, Maintained "Y-mAbs Therapeutics, Inc." (YMAB) at Strong Buy with Increased Target from $21 to $22 on, Jul 25th, 2023.

William has made no other calls on YMAB in the last 4 months.



There are 6 other peers that have a rating on YMAB. Out of the 6 peers that are also analyzing YMAB, 2 agree with William's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alec Stranahan of "B of A Securities" Maintained at Hold with Increased Target to $12 on, Monday, May 15th, 2023
  • Etzer Darout of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, April 3rd, 2023


These are the ratings of the 4 analyists that currently disagree with William


  • David Nierengarten of "Wedbush" Upgraded from Hold to Buy and Increased Target to $13 on, Wednesday, May 10th, 2023
  • Michael Ulz of "Morgan Stanley" Maintained at Sell with Increased Target to $7 on, Wednesday, May 10th, 2023
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $11 on, Tuesday, April 4th, 2023
  • William Maughan of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $18 on, Friday, March 31st, 2023

Publication Contributing Sources